(주) 뷰노

Press Releases

VUNO selected as a TOP 20 startup in MedTech Innovator Asia Pacific 2019

  • 09. 25. 2019

VUNO selected as a TOP 20 startup in MedTech Innovator Asia Pacific 2019

VUNO has been selected as a 20 Best-in-Class Startup in the MedTech Innovator Asia Pacific 2019 competition. MedTech Innovator is the premier global nonprofit that promotes promising startups in the medical technology industry.

MedTech Innovator is the medical technology industry’s global showcase and promoter for innovative medical device, digital health and diagnostic companies. It is the largest platform of its kind and over 170 companies applied for the Asia Pacific program, but only 40 startups from the 2019 Asia Pacific cohort advanced to compete in the regional pitch. Further information about MedTech Innovator can be found at https://medtechinnovator.org/asia-pacific/

VUNO has demonstrated its strengths that makes it a global leader in the healthcare AI industry; design capabilities through its own proprietary deep learning engine, “VUNO NET”, R&D know-how accumulated through top-class professionals, portfolio of various medical AI products, and high-quality medical data that was acquired in large quantities from networks established through MOU agreements with domestic and foreign medical institutions.  As a result, VUNO was selected as a top 20 start-up company in Asia-Pacific. The contest is currently under way, and the final results will be selected in October.

This is not the first time that VUNO has been recognized as a startup company with excellent potential in the global market. In 2015, the company won the top prize at the "GB Pitch Award" at the "beGLOBAL SEOL 2015," Asia's largest startup conference, and has also won the first prize in the Korean qualifying match for "Rising Expo," a startup competition for Japan's venture capital (VC) CyberAgent Ventures. In addition, VUNO ranked No. 1 in the AI Startup Challenge held by Amazon Web Services (AWS) in 2018, showing the company's unwavering growth.

 

VUNO, which has received huge global attention since its inception, is expected to take the lead in domestic and foreign medical AI industries

Tag in

#Press_Releases